Previous 10 | Next 10 |
Orchard Therapeutics (NASDAQ: ORTX ) announces presentations at the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation to be held from August 29 - September 1, 2020. More news on: Orchard Therapeutics plc, Healthcare stocks news, Read more ...
BOSTON and LONDON, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced presentations at the upcoming 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), taking place virtuall...
Orchard Therapeutics plc (ORTX) Q2 2020 Results Conference Call August 06, 2020 08:00 AM ET Company Participants Renee Leck - Investor Relations Bobby Gaspar - Chief Executive Officer Frank Thomas - Chief Operating Officer Conference Call Participants Yaron Werber - Cowen ...
The following slide deck was published by Orchard Therapeutics plc in conjunction with this Read more ...
Image source: The Motley Fool. Orchard Therapeutics (NASDAQ: ORTX) Q2 2020 Earnings Call Aug 6, 2020 , 8:00 a.m. ET Operator Continue reading
Orchard Therapeutics (NASDAQ: ORTX ) : Q2 GAAP EPS of -$0.48 misses by $0.05 . Revenue of $0.6M beats by $0.4M . Press Release More news on: Orchard Therapeutics plc, Earnings news and commentary, Healthcare stocks news,
Regulatory and Clinical Progress in MLD, MPS-I and MPS-IIIA Illustrate Execution in Neurometabolic Disorders; EU Regulatory Decision for Libmeldy ™ Expected in 2H 2020 MolMed and GSK Agreements Provide Near-term Manufacturing Capacity and Highlight Future Innovatio...
BOSTON and LONDON, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company is scheduled to present at the Wedbush PacGrow Healthcare Virtual Conference on August 11, 2020 at 9:10 AM ET. A live...
BOSTON and LONDON, July 30, 2020 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that the company will host a conference call and live webcast on Thursday, August 6, 2020, at 8:00 a.m. ET to review business updates and its second quarte...
Orchard Therapeutics ( ORTX ) was founded in 2015 and has been dedicated to advancing gene therapies for ultra-rare diseases. In 2018, they acquired GSK’s portfolio of gene therapies and became a public company. Orchard now has one of the most extensive and advanced pipelines in the g...
News, Short Squeeze, Breakout and More Instantly...
Orchard Therapeutics plc Company Name:
ORTX Stock Symbol:
NASDAQ Market:
Orchard Therapeutics plc Website:
TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, ...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...
Gene therapy being developed as a one-time treatment to address the underlying cause of the disease by inserting a functional copy of the human IDUA gene into a patient’s own hematopoietic stem cells HURCULES study to enroll 40 patients at clinical sites across the U.S....